Furthermore, blocking TGF-β signaling by silencing TGF-ΒR1 in HCC cells attenuates VE-cadherin/MMP-2/LAMC2 expression and inhibits cancer-associated fibroblast (CM-CAF)-promoted VM formation 68. This evidence concerns the gene MMP2 and hepatocellular carcinoma.